Optimal antimicrobial therapy: The balance of potency and exposure

Expert Opinion on Investigational Drugs

Volumn 15, Issue 4, 2006, Pages 335-337

  Tillotson, Glenn S ^a   Doern, Gary V ^b   Blondeau, Joseph M ^c  

^a Oscient Pharmaceuticals   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Community acquired respiratory tract infections; Fluoroquinolones; Urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; GATIFLOXACIN; GEMIFLOXACIN; KETOLIDE; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG POTENCY; DRUG USE; EDITORIAL; HUMAN; LOWER RESPIRATORY TRACT INFECTION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; SINGLE DRUG DOSE; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DRUG ADMINISTRATION SCHEDULE; HUMANS;

EID: 33645718155     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.15.4.335     Document Type: Editorial

References (7)

1. SONG J: Introduction: the goals of antimicrobial therapy. Int. J. Infect. Dis. (2003) 7:S1-S4.
2. MILO G, KATCHMAN EA, PAUL M, CHRISTIAENS T, BAERHEIM A, LEIBOVICI L: Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database Syst. Rev. (2005) 2:CD004682.
3. AUQUER F, CORDON F, GORINA E, CABALLERO JC, ADALID C, BATLLE J, AND URINARY TRACT INFECTION STUDY GROUP: Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women. Clin. Microbiol. Infect. (2002) 8:50-54.
4. TALAN DA, STAMM WE, HOOTON TM et al: Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. J. Am. Med. Assoc. (2000) 283:1583-1590.
5. PEREZ-GORRICHO B, RIPOLL M, AND PACE STUDY GROUP: Does short-course antibiotic therapy better meet patient expectations? Int. J. Antimic. Agents (2003) 21:222-228.
6. BLONDEAU JM: Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections. Expert Opin. Investig. Drugs (2001) 10:213-237.
7. BLONDEAU JM: Differential impact on macrolide compounds in the selection of macrolide nonsusceptible Streptococcus pneumoniae. Therapy (2005) 2:813-818.